CURRENT ASPECTS IN THE TREATMENT OF BRONCHIALASTHMA

Amartya De^*, Nripendra Nath Bala

B.C.D.A College of Pharmacy & Technology,

78, Jessore Road (South) Hridaypur, Barasat,

Kolkata – 700127.

*Corresponding Author:

E-mail address: amartyap.col30@rediffmail.com

Mobile no. 9051931652

Telephone no. 033-25842433

Tele Fax- 033-25842433

ABSTRACT

Asthma is increasing in prevalence worldwide and results in significant health care resources. Although many patients are suffering from asthma can be adequately treated with inhaled corticosteroids, an important number of patients are required additional therapy there are several number of options are available. In further minority of patients may develop severe persistent asthma which remains difficult to manage despite current pharmacological therapies. In this literature we emphasized current therapies viz. cytokine modulators AntiTNF agents, Beta2 agonist, Immune and Gene therapy beside that other drug delivery system which are used in Asthma and several outlines of directions which may progress the management of asthma in the future.

Cytokine Modulators, Anti-TNF agents, Beta₂ agonist, Immune therapy, Gene therapy, Antisense therapy & drug delivery